Gene · 10062
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between the rs2279238 and rs12221497 of the LXRA gene variants and diabetic retinopathy in the Slovenian cohort. | Gene | 2025 | 40691909 | PubTator, text mining | PubMed |
| Bridging prediction and reality: Comprehensive analysis of experimental and AlphaFold 2 full-length nuclear receptor structures. | Comput Struct Biotechnol J | 2025 | 40496892 | PubTator, text mining | PubMed |
| Temporal single-cell sequencing analysis reveals that GPNMB-expressing macrophages potentiate muscle regeneration. | Exp Mol Med | 2025 | 40490493 | PubTator, text mining | PubMed |
| Decoding the Liver-Heart Axis in Cardiometabolic Diseases. | Circ Res | 2025 | 40403112 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia. | J Transl Med | 2025 | 40369632 | PubTator, text mining | PubMed |
| Mediterranean Diet Modulates Gene Expression of Cholesterol Efflux Receptors in High-Risk Cardiovascular Patients. | Mol Nutr Food Res | 2025 | 40344371 | PubTator, text mining | PubMed |
| A 40-year challenge to resolve clinical questions through experimental/laboratory techniques. | Endocr J | 2025 | 40335288 | PubTator, text mining | PubMed |
| Probiotic membrane vesicles ameliorate atherosclerotic plaques by promoting lipid efflux and polarization of foamy macrophages. | J Nanobiotechnology | 2025 | 40241138 | PubTator, text mining | PubMed |
| Predicting survival and immune status of breast cancer patients based on prognostic features related to PANoptosis. | Discov Oncol | 2025 | 40232576 | PubTator, text mining | PubMed |
| Dietary oleic acid drives obesogenic adipogenesis via modulation of LXRα signaling. | Cell Rep | 2025 | 40208790 | PubTator, text mining | PubMed |
| S-Nitrosoglutathione Is Not a Substrate of OATP1B1, but Stimulates Its Expression and Activity. | Biomolecules | 2025 | 40149964 | PubTator, text mining | PubMed |
| Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis. | Mar Drugs | 2025 | 40137297 | PubTator, text mining | PubMed |
| Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies. | J Med Chem | 2025 | 40127224 | PubTator, text mining | PubMed |
| Mechanism of liver x receptor alpha in intestine, liver and adipose tissues in metabolic associated fatty liver disease. | Int J Biol Macromol | 2025 | 40112983 | PubTator, text mining | PubMed |
| CKN reduces TLR4-mediated inflammation and cerebral I/R injury by activating the LXRα/ABCA1 pathway in microglia. | Life Sci | 2025 | 40107493 | PubTator, text mining | PubMed |
| Protective functions of liver X receptor α on calcified aortic valve: involvement of regulating endoplasmic reticulum-mediated osteogenic differentiation. | Cardiovasc Res | 2025 | 40088465 | PubTator, text mining | PubMed |
| Animal Model Screening for Hyperlipidemic ICR Mice. | Int J Mol Sci | 2025 | 40076768 | PubTator, text mining | PubMed |
| Berberine Improves Ox-LDL-Induced Macrophage Efferocytosis Dysfunction and Alleviates Inflammation via the PPARγ/LXRα Pathway. | Tohoku J Exp Med | 2025 | 40058846 | PubTator, text mining | PubMed |
| Atypical antipsychotics impair the lipid-lowering and pleiotropic effects of simvastatin via activation of the ADMA-NOX-ROS pathway. | Biomed Pharmacother | 2025 | 40058152 | PubTator, text mining | PubMed |
| Letter by Teng et al Regarding Article, "LXRα Promotes Abdominal Aortic Aneurysm Formation Through UHRF1 Epigenetic Modification of miR-26b-3p". | Circulation | 2025 | 40029943 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10062/papers?page=7